DHFR and neoplasm: Molecules, such as ASNS or DHFR, that show a response to treatment are potential candidates for stratification of patients with regard to their sensitivity to anti-tumor treatment and might be targets in a specific group of patients for a combinatorial treatment approach in order to enhance therapy success [7].